Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Kala Pharmaceuticals Inc. (KALA)

7.25   0.02 (0.28%) 01-24 16:00
Open: 7.43 Pre. Close: 7.23
High: 7.7 Low: 6.79
Volume: 1,421,101 Market Cap: 262M
Kala Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of therapeutics using its proprietary nanoparticle-based Mucus Penetrating Particles technology, with focus on the treatment of eye diseases.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 7.709 - 7.739 7.739 - 7.769
Low: 6.719 - 6.752 6.752 - 6.784
Close: 7.195 - 7.247 7.247 - 7.299

Technical analysis

as of: 2020-01-24 4:33:15 PM
Overall:       
Stoxline posted a BUY today, same as yesterday. Upward movement continues.
Target: Six months: 8.99     One year: 10.50
Support: Support1: 5.17    Support2: 3.60
Resistance: Resistance1: 7.70    Resistance2: 8.99
Pivot: 5.59
Moving Average: MA(5): 6.84     MA(20): 5.12
MA(100): 4.19     MA(250): 5.58
MACD: MACD(12,26): 0.76     Signal(9): 0.51
Stochastic oscillator: %K(14,3): 89.92     %D(3): 90.63
RSI: RSI(14): 80.39
52-week: High: 9.25  Low: 3.24  Change(%): 38.4
Average Vol(K): 3-Month: 56258  10-Days: 104776

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
KALA has closed below upper band by 8.9%. Bollinger Bands are 263.1% wider than normal. The large width of the bands suggest high volatility as compared to KALA's normal range. The bands have been in this wide range for 10 bars. This is a sign that the current trend might continue.

Headline News

2019-11-16
Kala Pharmaceuticals (NASDAQ:KALA) Stock Rating Reaffirmed by HC Wainwright
HC Wainwright reissued their buy rating on shares of Kala Pharmaceuticals (NASDAQ:KALA) in a research note published on Monday, The Fly reports. They currently have a $10.00 price objective on the stock, down from their prior price objective of $12.00. Several other research analysts also recently commented on the stock. JPMorgan Chase & Co. cut […]

2019-11-07
Kala Pharmaceuticals (KALA) Reports Q3 Loss, Misses Revenue Estimates
Kala Pharma (KALA) delivered earnings and revenue surprises of -1.49% and -59.20%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 36.09
Shares Float (M) 23.20
% Held by Insiders 1.38
% Held by Institutions 80.95
Shares Short (K) 4160
Shares Short P. Month (K)

Stock Financials

EPS -2.890
Book Value (p.s.) 1.250
PEG Ratio -0.06
Profit Margin
Operating Margin -1871.58
Return on Assets (ttm) -46.7
Return on Equity (ttm) -199.2
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -2.518
Qtrly Earnings Growth
Operating Cash Flow (M) -90.50
Levered Free Cash Flow (M) -54.68

Stock Valuations

P/E -2.51
P/E Growth Ratio
P/BV 5.80
P/S 51.78
P/CF -2.89

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.